Anthony Antonelli is a partner in the Litigation practice of Paul Hastings and is based in the firm’s New York office. He concentrates his practice on the representation of individuals and entities in regulatory enforcement and white collar criminal matters before the United States Department of Justice (DOJ), the Securities and Exchange Commission (SEC), state attorneys general offices, FINRA, and other federal and state agencies. In addition, he has conducted a variety of internal investigations, including those involving the Foreign Corrupt Practices Act (FCPA), kickbacks and accounting irregularities. Mr. Antonelli also has broad-based experience representing clients in a variety of complex civil litigation matters, including those involving securities, derivative products and other financial instruments. He has handled cases involving a wide array of substantive legal issues, including breach of fiduciary duty, fraud, breach of contract, as well as federal and state securities laws.
Recent Representations
White Collar Criminal Defense, Regulatory Enforcement & Internal Investigations
- An investment advisor and leading collateral manager in connection with an SEC investigation involving the underwriting, structuring, marketing, and sale of collateralized debt obligations (CDOs) and collateralized loan obligations (CLOs)
- A chief compliance officer in connection with an investigation by FINRA involving Rule 105 of Regulation M
- A head of syndication at a major investment bank in an SEC investigation relating to CDOs
- A state investment office managing more than $20 billion in assets in connection with federal "pay-to-play" investigations concerning the role of placement agents in various hedge fund, private equity, public equity, and real estate investments made by the state
- Various corporate executives at a number of different financial institutions in connection with federal and state investigations involving the underwriting, structuring, sale and/or trading of CDOs, residential mortgage-backed securities (RMBS) and other securitizations
- A broker-dealer in connection with an investigation by FINRA involving equity research
- A financial institution, various corporate executives and a securities analyst in a series of unrelated insider trading investigations by the DOJ and SEC
- Various corporate executives of an investment technology and services company in connection with investigations by the DOJ and SEC involving trade execution practices
- A major financial institution in connection with a series of criminal, civil, and regulatory investigations into the underwriting, marketing, and sale of auction rate securities
- A former chief executive officer charged by the DOJ for securities fraud and conspiracy in connection with a finite reinsurance transaction
- A global pharmaceutical company in an internal investigation relating to sales and marketing practices in China
- A global biotechnology company in an internal investigation relating to revenue recognition practices
- An employee of a major auto parts manufacturer in connection with antitrust investigations by the DOJ and foreign regulators
Securities & Complex Commercial Litigation
- A major investment bank in defense of a purported antitrust class action relating to supranational, sovereign, and agency (SSA) bonds
- An asset management firm and its principals in a nationwide class action alleging fraud, breach of fiduciary duty, negligence and various contract claims relating to investments in Madoff securities
- An investment bank underwriter syndicate in defense of federal securities class action relating to SeaWorld Entertainment Inc.'s initial and secondary public stock offerings
- An investment bank underwriter syndicate in defense of a purported securities class action relating to the IPO of an immuno-oncology company
- An investment bank underwriter syndicate in defense of a purported securities class action relating to the public stock offering of an energy yield company
- An investment bank underwriter syndicate in defense of a purported securities class action relating to the IPO of a medical device company
- A financial institution and its board of directors in connection with a purported class action arising from a bank merger
- A worldwide apparel company and its board of directors in connection with a purported class action arising from the $2.9B acquisition of the company
- A financial services company and its officers and directors in purported securities class actions and derivative litigation
- A real estate investment firm in an action alleging claims for breach of contract and breaches of fiduciary duty arising from a $1.7 billion real estate portfolio transaction